Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 239.67 USD -0.21% Market Closed
Market Cap: 20B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Profitability Summary

50/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Laboratory Corporation of America Holdings

Revenue
12.7B USD
Cost of Revenue
-9.2B USD
Gross Profit
3.5B USD
Operating Expenses
-2.4B USD
Operating Income
1.1B USD
Other Expenses
-701.1m USD
Net Income
435.5m USD

Margins Comparison
Laboratory Corporation of America Holdings Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Laboratory Corporation of America Holdings
NYSE:LH
20.1B USD
28%
9%
3%
US
Cigna Corp
NYSE:CI
91.8B USD
11%
4%
1%
US
Cigna Group
XMUN:CGN
87.7B EUR
11%
4%
1%
US
CVS Health Corp
NYSE:CVS
73B USD
14%
3%
1%
DE
Fresenius Medical Care AG
XMUN:FME
24.9B EUR
25%
7%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR
24%
7%
-2%
US
Quest Diagnostics Inc
NYSE:DGX
18.3B USD
33%
14%
9%
US
DaVita Inc
NYSE:DVA
13.7B USD
33%
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.4B EUR
25%
7%
3%
AU
Sonic Healthcare Ltd
ASX:SHL
13.4B AUD
84%
9%
6%
US
Chemed Corp
NYSE:CHE
8.6B USD
36%
17%
13%
Country US
Market Cap 20.1B USD
Gross Margin
28%
Operating Margin
9%
Net Margin
3%
Country US
Market Cap 91.8B USD
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 87.7B EUR
Gross Margin
11%
Operating Margin
4%
Net Margin
1%
Country US
Market Cap 73B USD
Gross Margin
14%
Operating Margin
3%
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Gross Margin
24%
Operating Margin
7%
Net Margin
-2%
Country US
Market Cap 18.3B USD
Gross Margin
33%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 13.7B USD
Gross Margin
33%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 12.4B EUR
Gross Margin
25%
Operating Margin
7%
Net Margin
3%
Country AU
Market Cap 13.4B AUD
Gross Margin
84%
Operating Margin
9%
Net Margin
6%
Country US
Market Cap 8.6B USD
Gross Margin
36%
Operating Margin
17%
Net Margin
13%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Laboratory Corporation of America Holdings Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Laboratory Corporation of America Holdings
NYSE:LH
20.1B USD
5%
2%
8%
5%
US
Cigna Corp
NYSE:CI
91.8B USD
7%
2%
10%
7%
US
Cigna Group
XMUN:CGN
87.7B EUR
7%
2%
10%
7%
US
CVS Health Corp
NYSE:CVS
73B USD
7%
2%
7%
4%
DE
Fresenius Medical Care AG
XMUN:FME
24.9B EUR
4%
2%
5%
3%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR
-2%
-1%
4%
1%
US
Quest Diagnostics Inc
NYSE:DGX
18.3B USD
13%
6%
10%
8%
US
DaVita Inc
NYSE:DVA
13.7B USD
104%
5%
13%
10%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.4B EUR
4%
2%
5%
3%
AU
Sonic Healthcare Ltd
ASX:SHL
13.4B AUD
7%
4%
7%
5%
US
Chemed Corp
NYSE:CHE
8.6B USD
27%
18%
29%
22%
Country US
Market Cap 20.1B USD
ROE
5%
ROA
2%
ROCE
8%
ROIC
5%
Country US
Market Cap 91.8B USD
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 87.7B EUR
ROE
7%
ROA
2%
ROCE
10%
ROIC
7%
Country US
Market Cap 73B USD
ROE
7%
ROA
2%
ROCE
7%
ROIC
4%
Country DE
Market Cap 24.9B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country DE
Market Cap 18.8B EUR
ROE
-2%
ROA
-1%
ROCE
4%
ROIC
1%
Country US
Market Cap 18.3B USD
ROE
13%
ROA
6%
ROCE
10%
ROIC
8%
Country US
Market Cap 13.7B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
10%
Country DE
Market Cap 12.4B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country AU
Market Cap 13.4B AUD
ROE
7%
ROA
4%
ROCE
7%
ROIC
5%
Country US
Market Cap 8.6B USD
ROE
27%
ROA
18%
ROCE
29%
ROIC
22%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top